Differences  ||| S:0 E:12 ||| NNS
in  ||| S:12 E:15 ||| IN
the  ||| S:15 E:19 ||| DT
expression  ||| S:19 E:30 ||| NN
of  ||| S:30 E:33 ||| IN
TLRs  ||| S:33 E:38 ||| JJ
and  ||| S:38 E:42 ||| CC
inflammatory  ||| S:42 E:55 ||| JJ
cytokines  ||| S:55 E:65 ||| NN
in  ||| S:65 E:68 ||| IN
pre-eclamptic  ||| S:68 E:82 ||| JJ
compared  ||| S:82 E:91 ||| VBN
with  ||| S:91 E:96 ||| IN
healthy  ||| S:96 E:104 ||| JJ
pregnant  ||| S:104 E:113 ||| JJ
women  ||| S:113 E:119 ||| NNS
Preeclampsia  ||| S:119 E:132 ||| NNP
( ||| S:132 E:133 ||| -LRB-
PE ||| S:133 E:135 ||| NNP
)  ||| S:135 E:137 ||| -RRB-
is  ||| S:137 E:140 ||| VBZ
one  ||| S:140 E:144 ||| CD
of  ||| S:144 E:147 ||| IN
the  ||| S:147 E:151 ||| DT
most  ||| S:151 E:156 ||| RBS
complex  ||| S:156 E:164 ||| JJ
and  ||| S:164 E:168 ||| CC
life-threatening  ||| S:168 E:185 ||| JJ
pregnancy  ||| S:185 E:195 ||| NN
disorders  ||| S:195 E:205 ||| NNS
and  ||| S:205 E:209 ||| CC
is  ||| S:209 E:212 ||| VBZ
considered  ||| S:212 E:223 ||| VBN
as  ||| S:223 E:226 ||| IN
a  ||| S:226 E:228 ||| DT
major  ||| S:228 E:234 ||| JJ
cause  ||| S:234 E:240 ||| NN
of  ||| S:240 E:243 ||| IN
mortality  ||| S:243 E:253 ||| NN
among  ||| S:253 E:259 ||| IN
mothers  ||| S:259 E:267 ||| NNS
and  ||| S:267 E:271 ||| CC
fetuses  ||| S:271 E:279 ||| JJ
worldwide ||| S:279 E:288 ||| NN
.  ||| S:288 E:290 ||| .
Although  ||| S:290 E:299 ||| IN
the  ||| S:299 E:303 ||| DT
exact  ||| S:303 E:309 ||| JJ
etiology  ||| S:309 E:318 ||| NN
of  ||| S:318 E:321 ||| IN
PE  ||| S:321 E:324 ||| NNP
is  ||| S:324 E:327 ||| VBZ
not  ||| S:327 E:331 ||| RB
well  ||| S:331 E:336 ||| RB
known  ||| S:336 E:342 ||| VBN
several  ||| S:342 E:350 ||| JJ
lines  ||| S:350 E:356 ||| NNS
of  ||| S:356 E:359 ||| IN
evidence  ||| S:359 E:368 ||| NN
support  ||| S:368 E:376 ||| NN
an  ||| S:376 E:379 ||| DT
immunological  ||| S:379 E:393 ||| JJ
etiology  ||| S:393 E:402 ||| NN
for  ||| S:402 E:406 ||| IN
PE ||| S:406 E:408 ||| NNP
.  ||| S:408 E:410 ||| .
To  ||| S:410 E:413 ||| TO
investigate  ||| S:413 E:425 ||| VB
the  ||| S:425 E:429 ||| DT
differences  ||| S:429 E:441 ||| NNS
in  ||| S:441 E:444 ||| IN
the  ||| S:444 E:448 ||| DT
expression  ||| S:448 E:459 ||| NN
of  ||| S:459 E:462 ||| IN
TLRs  ||| S:462 E:467 ||| JJ
2 ||| S:467 E:468 ||| CD
,  ||| S:468 E:470 ||| ,
4 ||| S:470 E:471 ||| CD
,  ||| S:471 E:473 ||| ,
5 ||| S:473 E:474 ||| CD
,  ||| S:474 E:476 ||| ,
and  ||| S:476 E:480 ||| CC
6  ||| S:480 E:482 ||| CD
and  ||| S:482 E:486 ||| CC
a  ||| S:486 E:488 ||| DT
group  ||| S:488 E:494 ||| NN
of  ||| S:494 E:497 ||| IN
inflammatory  ||| S:497 E:510 ||| JJ
cytokines  ||| S:510 E:520 ||| NNS
including  ||| S:520 E:530 ||| VBG
IL-1 ||| S:530 E:534 ||| NNP
,  ||| S:534 E:536 ||| ,
IL-6 ||| S:536 E:540 ||| NNP
,  ||| S:540 E:542 ||| ,
TNF-α  ||| S:542 E:548 ||| JJ
and  ||| S:548 E:552 ||| CC
IFN-γ  ||| S:552 E:558 ||| JJ
in  ||| S:558 E:561 ||| IN
placentas  ||| S:561 E:571 ||| NN
from  ||| S:571 E:576 ||| IN
PE  ||| S:576 E:579 ||| NNP
and  ||| S:579 E:583 ||| CC
healthy  ||| S:583 E:591 ||| JJ
pregnant  ||| S:591 E:600 ||| JJ
women  ||| S:600 E:606 ||| NNS
in  ||| S:606 E:609 ||| IN
their  ||| S:609 E:615 ||| PRP$
third  ||| S:615 E:621 ||| JJ
trimester  ||| S:621 E:631 ||| NN
of  ||| S:631 E:634 ||| IN
pregnancy ||| S:634 E:643 ||| NN
.  ||| S:643 E:645 ||| .
This  ||| S:645 E:650 ||| DT
case-control  ||| S:650 E:663 ||| JJ
study  ||| S:663 E:669 ||| NN
was  ||| S:669 E:673 ||| VBD
performed  ||| S:673 E:683 ||| VBN
on  ||| S:683 E:686 ||| IN
fifteen  ||| S:686 E:694 ||| JJ
PE  ||| S:694 E:697 ||| NNP
and  ||| S:697 E:701 ||| CC
fifteen  ||| S:701 E:709 ||| JJ
age  ||| S:709 E:713 ||| NN
and  ||| S:713 E:717 ||| CC
gestational  ||| S:717 E:729 ||| VB
matched  ||| S:729 E:737 ||| VBN
healthy  ||| S:737 E:745 ||| JJ
pregnant  ||| S:745 E:754 ||| JJ
women  ||| S:754 E:760 ||| NNS
in  ||| S:760 E:763 ||| IN
the  ||| S:763 E:767 ||| DT
third  ||| S:767 E:773 ||| JJ
trimester  ||| S:773 E:783 ||| NN
of  ||| S:783 E:786 ||| IN
pregnancy ||| S:786 E:795 ||| NN
.  ||| S:795 E:797 ||| .
Real  ||| S:797 E:802 ||| JJ
time  ||| S:802 E:807 ||| NN
PCR  ||| S:807 E:811 ||| NNP
( ||| S:811 E:812 ||| -LRB-
RT-PCR ||| S:812 E:818 ||| NNP
)  ||| S:818 E:820 ||| -RRB-
technique  ||| S:820 E:830 ||| NN
was  ||| S:830 E:834 ||| VBD
used  ||| S:834 E:839 ||| VBN
to  ||| S:839 E:842 ||| TO
determine  ||| S:842 E:852 ||| VB
the  ||| S:852 E:856 ||| DT
expression  ||| S:856 E:867 ||| NN
of  ||| S:867 E:870 ||| IN
TLRs  ||| S:870 E:875 ||| JJ
2 ||| S:875 E:876 ||| CD
,  ||| S:876 E:878 ||| ,
4 ||| S:878 E:879 ||| CD
,  ||| S:879 E:881 ||| ,
5 ||| S:881 E:882 ||| CD
,  ||| S:882 E:884 ||| ,
and  ||| S:884 E:888 ||| CC
6  ||| S:888 E:890 ||| CD
in  ||| S:890 E:893 ||| IN
the  ||| S:893 E:897 ||| DT
maternal  ||| S:897 E:906 ||| NN
and  ||| S:906 E:910 ||| CC
fetal  ||| S:910 E:916 ||| JJ
parts  ||| S:916 E:922 ||| NNS
of  ||| S:922 E:925 ||| IN
the  ||| S:925 E:929 ||| DT
placenta ||| S:929 E:937 ||| NN
.  ||| S:937 E:939 ||| .
Moreover ||| S:939 E:947 ||| RB
,  ||| S:947 E:949 ||| ,
the  ||| S:949 E:953 ||| DT
expressions  ||| S:953 E:965 ||| NNS
of  ||| S:965 E:968 ||| IN
IL-1 ||| S:968 E:972 ||| NNP
,  ||| S:972 E:974 ||| ,
IL-6 ||| S:974 E:978 ||| NNP
,  ||| S:978 E:980 ||| ,
TNF-α  ||| S:980 E:986 ||| JJ
and  ||| S:986 E:990 ||| CC
IFN-γ  ||| S:990 E:996 ||| JJ
at  ||| S:996 E:999 ||| IN
RNA  ||| S:999 E:1003 ||| NNP
level  ||| S:1003 E:1009 ||| NN
in  ||| S:1009 E:1012 ||| IN
placental  ||| S:1012 E:1022 ||| JJ
samples ||| S:1022 E:1029 ||| NNS
,  ||| S:1029 E:1031 ||| ,
peripheral ||| S:1031 E:1041 ||| JJ
,  ||| S:1041 E:1043 ||| ,
and  ||| S:1043 E:1047 ||| CC
cord  ||| S:1047 E:1052 ||| JJ
blood  ||| S:1052 E:1058 ||| NN
were  ||| S:1058 E:1063 ||| VBD
investigated ||| S:1063 E:1075 ||| VBN
.  ||| S:1075 E:1077 ||| .
The  ||| S:1077 E:1081 ||| DT
results  ||| S:1081 E:1089 ||| NNS
of  ||| S:1089 E:1092 ||| IN
the  ||| S:1092 E:1096 ||| DT
present  ||| S:1096 E:1104 ||| JJ
study  ||| S:1104 E:1110 ||| NN
indicated  ||| S:1110 E:1120 ||| VBD
that  ||| S:1120 E:1125 ||| IN
the  ||| S:1125 E:1129 ||| DT
expressions  ||| S:1129 E:1141 ||| NNS
of  ||| S:1141 E:1144 ||| IN
TLRs  ||| S:1144 E:1149 ||| JJ
4 ||| S:1149 E:1150 ||| CD
,  ||| S:1150 E:1152 ||| ,
5  ||| S:1152 E:1154 ||| CD
and  ||| S:1154 E:1158 ||| CC
6  ||| S:1158 E:1160 ||| CD
were  ||| S:1160 E:1165 ||| VBD
significantly  ||| S:1165 E:1179 ||| RB
increased  ||| S:1179 E:1189 ||| VBN
in  ||| S:1189 E:1192 ||| IN
both  ||| S:1192 E:1197 ||| DT
maternal  ||| S:1197 E:1206 ||| JJ
part  ||| S:1206 E:1211 ||| NN
( ||| S:1211 E:1212 ||| -LRB-
p  ||| S:1212 E:1213 ||| FW
< ||| S:1213 E:1214 ||| SYM
0.001  ||| S:1214 E:1220 ||| FW
and  ||| S:1220 E:1224 ||| CC
p  ||| S:1224 E:1225 ||| JJ
< ||| S:1225 E:1226 ||| SYM
0.003  ||| S:1226 E:1232 ||| NN
for  ||| S:1232 E:1236 ||| IN
TLRs  ||| S:1236 E:1241 ||| JJ
4 ||| S:1241 E:1242 ||| CD
,  ||| S:1242 E:1244 ||| ,
6  ||| S:1244 E:1246 ||| CD
and  ||| S:1246 E:1250 ||| CC
TLR  ||| S:1250 E:1254 ||| NNP
5 ||| S:1254 E:1255 ||| CD
,  ||| S:1255 E:1257 ||| ,
respectively ||| S:1257 E:1269 ||| RB
)  ||| S:1269 E:1271 ||| -RRB-
and  ||| S:1271 E:1275 ||| CC
fetal  ||| S:1275 E:1281 ||| JJ
part  ||| S:1281 E:1286 ||| NN
( ||| S:1286 E:1287 ||| -LRB-
p  ||| S:1287 E:1288 ||| FW
< ||| S:1288 E:1289 ||| SYM
0.001 ||| S:1289 E:1294 ||| FW
) ||| S:1294 E:1295 ||| -RRB-
,  ||| S:1295 E:1297 ||| ,
while  ||| S:1297 E:1303 ||| IN
TLR2  ||| S:1303 E:1308 ||| NNP
showed  ||| S:1308 E:1315 ||| VBD
significant  ||| S:1315 E:1327 ||| JJ
increase  ||| S:1327 E:1336 ||| NN
only  ||| S:1336 E:1341 ||| RB
in  ||| S:1341 E:1344 ||| IN
the  ||| S:1344 E:1348 ||| DT
fetal  ||| S:1348 E:1354 ||| JJ
part  ||| S:1354 E:1359 ||| NN
of  ||| S:1359 E:1362 ||| IN
PE  ||| S:1362 E:1365 ||| NNP
placentas  ||| S:1365 E:1375 ||| NNS
( ||| S:1375 E:1376 ||| -LRB-
p  ||| S:1376 E:1377 ||| FW
< ||| S:1377 E:1378 ||| SYM
0.002 ||| S:1378 E:1383 ||| FW
) ||| S:1383 E:1384 ||| -RRB-
.  ||| S:1384 E:1386 ||| .
The  ||| S:1386 E:1390 ||| DT
levels  ||| S:1390 E:1397 ||| NNS
of  ||| S:1397 E:1400 ||| IN
all  ||| S:1400 E:1404 ||| DT
studied  ||| S:1404 E:1412 ||| JJ
cytokines  ||| S:1412 E:1422 ||| NN
showed  ||| S:1422 E:1429 ||| VBD
over-expression  ||| S:1429 E:1445 ||| JJ
within  ||| S:1445 E:1452 ||| IN
peripheral  ||| S:1452 E:1463 ||| JJ
and  ||| S:1463 E:1467 ||| CC
cord  ||| S:1467 E:1472 ||| JJ
blood  ||| S:1472 E:1478 ||| NN
samples  ||| S:1478 E:1486 ||| NNS
from  ||| S:1486 E:1491 ||| IN
PE  ||| S:1491 E:1494 ||| NNP
patients  ||| S:1494 E:1503 ||| NNS
( ||| S:1503 E:1504 ||| -LRB-
p  ||| S:1504 E:1505 ||| JJ
< ||| S:1505 E:1506 ||| SYM
0.001  ||| S:1506 E:1512 ||| NN
for  ||| S:1512 E:1516 ||| IN
IL-1 ||| S:1516 E:1520 ||| NNP
,  ||| S:1520 E:1522 ||| ,
IL-6 ||| S:1522 E:1526 ||| NNP
,  ||| S:1526 E:1528 ||| ,
and  ||| S:1528 E:1532 ||| CC
IFN-γ  ||| S:1532 E:1538 ||| JJ
and  ||| S:1538 E:1542 ||| CC
p  ||| S:1542 E:1543 ||| JJ
< ||| S:1543 E:1544 ||| SYM
0.004  ||| S:1544 E:1550 ||| NN
for  ||| S:1550 E:1554 ||| IN
TNF-α  ||| S:1554 E:1560 ||| JJ
in  ||| S:1560 E:1563 ||| IN
both  ||| S:1563 E:1568 ||| DT
cord  ||| S:1568 E:1573 ||| NN
and  ||| S:1573 E:1577 ||| CC
peripheral  ||| S:1577 E:1588 ||| JJ
blood  ||| S:1588 E:1594 ||| NN
samples ||| S:1594 E:1601 ||| NNS
) ||| S:1601 E:1602 ||| -RRB-
.  ||| S:1602 E:1604 ||| .
The  ||| S:1604 E:1608 ||| DT
finding  ||| S:1608 E:1616 ||| NN
of  ||| S:1616 E:1619 ||| IN
the  ||| S:1619 E:1623 ||| DT
present  ||| S:1623 E:1631 ||| JJ
study  ||| S:1631 E:1637 ||| NN
indicated  ||| S:1637 E:1647 ||| VBD
that  ||| S:1647 E:1652 ||| IN
the  ||| S:1652 E:1656 ||| DT
expression  ||| S:1656 E:1667 ||| NN
of  ||| S:1667 E:1670 ||| IN
the  ||| S:1670 E:1674 ||| DT
studied  ||| S:1674 E:1682 ||| VBN
TLRs  ||| S:1682 E:1687 ||| JJ
and  ||| S:1687 E:1691 ||| CC
inflammatory  ||| S:1691 E:1704 ||| JJ
cytokines  ||| S:1704 E:1714 ||| NNS
are  ||| S:1714 E:1718 ||| VBP
generally  ||| S:1718 E:1728 ||| RB
suppressed  ||| S:1728 E:1739 ||| VBN
in  ||| S:1739 E:1742 ||| IN
normal  ||| S:1742 E:1749 ||| JJ
pregnancy ||| S:1749 E:1758 ||| NN
,  ||| S:1758 E:1760 ||| ,
but  ||| S:1760 E:1764 ||| CC
are  ||| S:1764 E:1768 ||| VBP
up  ||| S:1768 E:1771 ||| RB
regulated  ||| S:1771 E:1781 ||| VBN
in  ||| S:1781 E:1784 ||| IN
preeclamptic  ||| S:1784 E:1797 ||| JJ
women ||| S:1797 E:1802 ||| NNS
.  ||| S:1802 E:1804 ||| .
Moreover ||| S:1804 E:1812 ||| RB
,  ||| S:1812 E:1814 ||| ,
it  ||| S:1814 E:1817 ||| PRP
seems  ||| S:1817 E:1823 ||| VBZ
that  ||| S:1823 E:1828 ||| IN
the  ||| S:1828 E:1832 ||| DT
maternal  ||| S:1832 E:1841 ||| NN
and  ||| S:1841 E:1845 ||| CC
fetal  ||| S:1845 E:1851 ||| JJ
parts  ||| S:1851 E:1857 ||| NNS
of  ||| S:1857 E:1860 ||| IN
the  ||| S:1860 E:1864 ||| DT
placenta  ||| S:1864 E:1873 ||| NN
may  ||| S:1873 E:1877 ||| MD
play  ||| S:1877 E:1882 ||| VB
different  ||| S:1882 E:1892 ||| JJ
roles  ||| S:1892 E:1898 ||| NNS
in  ||| S:1898 E:1901 ||| IN
the  ||| S:1901 E:1905 ||| DT
induction  ||| S:1905 E:1915 ||| NN
of  ||| S:1915 E:1918 ||| IN
the  ||| S:1918 E:1922 ||| DT
inflammatory  ||| S:1922 E:1935 ||| JJ
status  ||| S:1935 E:1942 ||| NN
within  ||| S:1942 E:1949 ||| IN
the  ||| S:1949 E:1953 ||| DT
placenta ||| S:1953 E:1961 ||| NN
.  ||| S:1961 E:1963 ||| .
